PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
RYTM vs. CVD.TO
Performance
Return for Risk
Drawdowns
Volatility
Dividends

RYTM vs. CVD.TO

Last updated Jun 13, 2026

RYTM (Rhythm Pharmaceuticals, Inc.) is a stock, while CVD.TO (iShares Convertible Bond Index ETF) is High Yield Bonds fund tracking the FTSE Canada Convertible Bond Index. Over the past 5 years, RYTM returned 35.88%/yr vs 1.48%/yr for CVD.TO. At a 0.04 correlation, their price movements are largely independent.

Performance

RYTM vs. CVD.TO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Rhythm Pharmaceuticals, Inc. (RYTM) and iShares Convertible Bond Index ETF (CVD.TO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

RYTM is traded in USD, while CVD.TO is traded in CAD. To make them comparable, the CVD.TO values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, RYTM achieves a -17.43% return, which is significantly lower than CVD.TO's 1.91% return.

RYTM

1D
0.82%
1M
-2.36%
YTD
-17.43%
6M
-22.17%
1Y
40.51%
3Y*
70.57%
5Y*
35.88%
10Y*
—

CVD.TO

1D
-0.62%
1M
-0.61%
YTD
1.91%
6M
-0.80%
1Y
4.81%
3Y*
6.52%
5Y*
1.48%
10Y*
3.68%
*Multi-year figures are annualized to reflect compound growth (CAGR)

RYTM vs. CVD.TO - Yearly Performance Comparison

2026 (YTD)202520242023202220212020201920182017
RYTM
Rhythm Pharmaceuticals, Inc.		-17.43%91.21%21.78%57.86%191.78%-66.43%29.49%-14.58%-7.50%25.20%
CVD.TO
iShares Convertible Bond Index ETF		1.91%12.22%3.88%6.17%-10.31%5.38%6.19%15.02%-10.23%0.99%

Correlation

The correlation between RYTM and CVD.TO is -0.15, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.

Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.15

Correlation (3Y)
Calculated over the trailing 3-year period

0.01

Correlation (5Y)
Calculated over the trailing 5-year period

0.01

Correlation (All Time)
Calculated using the full available price history since Oct 5, 2017

0.04

The correlation between RYTM and CVD.TO shifts across timeframes, from -0.15 (1 year) to 0.04 (all time), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Rhythm Pharmaceuticals, Inc.

iShares Convertible Bond Index ETF

Often compared with RYTM:
RYTM vs. TGTXRYTM vs. VGTRYTM vs. ICLNRYTM vs. VKTXRYTM vs. TPRRYTM vs. CLSRYTM vs. AVGO
Often compared with CVD.TO:
CVD.TO vs. ZWC.TOCVD.TO vs. ICVTCVD.TO vs. XHY.TOCVD.TO vs. CGHY.TOCVD.TO vs. XHB.TOCVD.TO vs. ZHY.TOCVD.TO vs. XSB.TO

Return for Risk

RYTM vs. CVD.TO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
RYTM
RYTM Risk / Return Rank: 6767
Overall Rank
RYTM Sharpe Ratio Rank: 6666
Sharpe Ratio Rank
RYTM Sortino Ratio Rank: 7171
Sortino Ratio Rank
RYTM Omega Ratio Rank: 6666
Omega Ratio Rank
RYTM Calmar Ratio Rank: 6666
Calmar Ratio Rank
RYTM Martin Ratio Rank: 6666
Martin Ratio Rank
CVD.TO
CVD.TO Risk / Return Rank: 3535
Overall Rank
CVD.TO Sharpe Ratio Rank: 3232
Sharpe Ratio Rank
CVD.TO Sortino Ratio Rank: 2929
Sortino Ratio Rank
CVD.TO Omega Ratio Rank: 3535
Omega Ratio Rank
CVD.TO Calmar Ratio Rank: 4242
Calmar Ratio Rank
CVD.TO Martin Ratio Rank: 3838
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RYTM vs. CVD.TO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Rhythm Pharmaceuticals, Inc. (RYTM) and iShares Convertible Bond Index ETF (CVD.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

RYTMCVD.TODifference
Sharpe ratioReturn per unit of total volatility
0.71
0.58

+0.13

Sortino ratioReturn per unit of downside risk
1.64
0.84

+0.80

Omega ratioGain probability vs. loss probability

1.19

1.11

+0.08

Calmar ratioReturn relative to maximum drawdown

1.14

1.24

-0.11

Martin ratioReturn relative to average drawdown

2.64

2.65

-0.02

RYTM vs. CVD.TO - Sharpe Ratio Comparison

The current RYTM Sharpe Ratio is 0.71, which is comparable to the CVD.TO Sharpe Ratio of 0.58. The chart below compares the historical Sharpe Ratios of RYTM and CVD.TO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Loading charts...

Drawdowns

RYTM vs. CVD.TO - Drawdown Comparison

The maximum RYTM drawdown since its inception was -92.10%, which is greater than CVD.TO's maximum drawdown of -34.37%. Use the drawdown chart below to compare losses from any high point for RYTM and CVD.TO.

Loading charts...

Drawdown Indicators

RYTMCVD.TODifference

Max Drawdown

Largest peak-to-trough decline

-92.10%

-34.37%

-57.73%

Max Drawdown (1Y)

Largest decline over 1 year

-35.54%

-4.02%

-31.52%

Max Drawdown (3Y)

Largest decline over 3 years

-35.54%

-14.52%

-21.02%

Max Drawdown (5Y)

Largest decline over 5 years

-85.09%

-22.91%

-62.18%

Max Drawdown (10Y)

Largest decline over 10 years

—

-30.24%

—

Current Drawdown

Current decline from peak

-24.86%

-3.39%

-21.47%

Average Drawdown

Average peak-to-trough decline

-32.15%

-9.33%

-22.82%

Ulcer Index

Depth and duration of drawdowns from previous peaks

15.31%

1.88%

+13.43%

Volatility

RYTM vs. CVD.TO - Volatility Comparison

Rhythm Pharmaceuticals, Inc. (RYTM) has a higher volatility of 11.87% compared to iShares Convertible Bond Index ETF (CVD.TO) at 1.80%. This indicates that RYTM's price experiences larger fluctuations and is considered to be riskier than CVD.TO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading charts...

Volatility by Period

RYTMCVD.TODifference

Volatility (1M)

Calculated over the trailing 1-month period

11.87%

1.80%

+10.07%

Volatility (6M)

Calculated over the trailing 6-month period

36.41%

6.69%

+29.72%

Volatility (1Y)

Calculated over the trailing 1-year period

57.20%

8.63%

+48.57%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

76.39%

11.38%

+65.01%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

71.57%

11.79%

+59.78%

Dividends

RYTM vs. CVD.TO - Dividend Comparison

RYTM has not paid dividends to shareholders, while CVD.TO's dividend yield for the trailing twelve months is around 4.91%.

PositionTTM20252024202320222021202020192018201720162015
CVD.TO
iShares Convertible Bond Index ETF		4.91%4.91%5.14%5.33%5.05%4.61%4.48%4.52%4.97%4.65%4.51%4.94%
RYTM
Rhythm Pharmaceuticals, Inc.		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions

RYTM and CVD.TO have a correlation of -0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for RYTM and CVD.TO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer